OrphoMed is a biopharmaceutical company that develops dimer therapies for visceral hypersensitivity and hypermotility in gastrointestinal disorders.
Business Model:
Revenue: $3M
Employees: 2-10
Address: 50 Francisco Street
City: San Francisco
State: CA
Zip: 94133
Country: US
OrphoMed is a biopharmaceutical company that develops dimer therapies for visceral hypersensitivity and hypermotility in gastrointestinal disorders.
Contact Phone:
+14155694417
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2015 | Seed | $2.8M | 4/2020 | Debt | $150k |
U.S. Small Business Administration. |
5/2017 | Series A | 5 | $39M |
Mario Family Funds New Enterprise Associates Pappas Capital Relativity Healthcare Partners Takeda Ventures Mario Family Funds New Enterprise Associates Pappas Capital Relativity Healthcare Partners Takeda Ventures |
1/2016 | Debt Financing | $2.8M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|